Trial intelligence / Profile preview

Safety of Heparin Blausiegel vs Liquemine in Chronic Renal Failure

NCT01229072Phase 3Suspended

Sponsor
Azidus Laboratories Limited
Start
Jul 2008
Primary completion
Jul 2008
Modality
Recombinant Proteins and Enzymes, Small Molecules
Countries
1
01

Overview

A Phase 3 trial of heparin in thrombosis, sponsored by Azidus Laboratories Limited. Started Jul 2008; status: suspended.

02

Drugs

heparin
03

Conditions

thrombosis

Beyond the preview

Go deeper on NCT01229072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01229072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call